AMC Stock Price Forecast: Why the initial reopening downfall may serve as a buying opportunity

NYSE: AMC is kicking off the new week with another slide.
Concerns about low ticket prices and reduced attendance are weighing on AMC Theaters.
The slow reopening may precede a more significant return later on.

Back to the Future – the classic 1980s series – is one of the films aired at AMC Theaters as they reopen. The return of films has been received with little enthusiasm by investors that are worried about low prices and limited attendance.

In order to ensure safety, the Leawood, Kansas-based cinema operator has significantly reduced the number of people in its venues and also installed plexiglass separations. Moviegoers are asked to wear face masks and use sanitizing gel.

Costs from implementing the new measures and lower attendance are joined by reduced prices – as low as 15 cents in some places – meant to lure people to the big screen. Despite reports that some theaters are sold out, NYSE: AMC shares have been on the back foot.

Are markets anxious about a happy end to the coronavirus saga? That seems to be the message, yet there is also a "director's cut" that bargain seeker may opt to narrate.

AMC Theaters Stock

NYSE: AMCis struggling around the $5 mark, down from $5.19 in the previous close. The 52-week high is $12.13 and the trough was $1.95. Support is seen around the pre-surge peak of $4.75 and resistance is at Thursday's close of $5.69.

The initial disappointment from reopening cinemas with low prices and limited capacity allows for a safe and gradual return to normal – something that Adam Aron's company can weather. Once hesitant cinephiles see that going to the movies is not as hazardous as previously feared, they may make their way back.

Enhanced demand could result in higher prices – regardless of the disease – and later by relaxing some of the measures, such as allowing more people to enter closed spaces. AMC Theaters' management insists that safety is a top priority and is this message is tied to reality, shares could resume their rise.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.